Angiotensin-converting enzyme (ACE) inhibitors improved all-cause mortality, cardiovascular mortality, and major cardiovascular events compared with angiotensin II receptor blockers (ARBs) in patients with diabetes, a new study found.
A study and a meta-analysis suggest incretin-based drugs don't increase the risk of pancreatitis in patients with type 2 diabetes.
Two novel algorithms to individualize glycemic control targets would allow clinicians to set HbA1c goals, reclassify from one-quarter to one-third of patients as controlled instead of uncontrolled, and possibly improve treatment of certain patient populations, a study found.
To screen at-risk patients for albuminuria, quantitative tests can be used effectively at the point of care, but semiquantitative tests are not sufficiently accurate, a recent meta-analysis found.
Adding lisinopril to losartan increased hyperkalemia and acute kidney injury in type 2 diabetes and proteinuria
In a trial of more than 1,000 diabetic patients with proteinuria, adding an ACE inhibitor to an ARB didn't improve estimated glomerular filtration rate and increased risk for hyperkalemia and acute kidney injury, so the trial was halted early.
Several recent analyses of national health care data assessed the prevalence of diabetes and its complications in the U.S.